×
模态框（Modal）标题
在这里添加一些文本
Close
Close
Submit
Cancel
Confirm
×
模态框（Modal）标题
×
Please choose a citation manager
RIS (ProCite, Reference Manager)
BibTeX
Content to export
Citation
Citation and abstract
Export
Close ×
Home
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
中文
Home
About Journal
Instruction
Journals Online
Just Accepted
Current Issue
Archive
Most Read
Most Download
Most Cited
E-mail Alert
Editorial Board
Publishing Policy
Download
Contacts Us
中文
Author Login
Peer Review
Office Work
Editor-in-Chief
Volume 39 Issue 5
Directed：
National Medical Products Administration
Sponsored:
National Institutes for Food and Drug Control
Editor in Chief:
Sang Guowei
Edited & Published:
Editors Agency of
Chinese Pharmaceutical Affairs
ISSN:
1002-7777
CN:
11-2858/R
Highlights
More
Collections
More +
Current Issue
Archive
Most Download
Most Read
Most Cited
Volume 39 Issue 5
20 May 2025
Supervision & Administration
Comparative Analysis of the Implementation of Wholesale and Retail Integration Policy of Drug Business in Some Provinces of China
Qiu Yan, Liu Mingpu, Zhang Jihui, Huang Zekai, Du Liyun, Zhang Chuiliu
2025, 39(5): 485-491.
https://doi.org/10.16153/j.1002-7777.2025-03-0027
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Analysis of Risks and Suggestions on Online Drug Sales
Xu Weixing
2025, 39(5): 492-498.
https://doi.org/10.16153/j.1002-7777.2025-02-0034
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Considerations for Pharmaceutical Research of Genome Editing Systems in Advanced Therapy Medicinal Products
Yin Huifang, Wei Xuejing, Dai Yifei, Ma Xiaojuan, Zhang Jingchen
2025, 39(5): 499-505.
https://doi.org/10.16153/j.1002-7777.2024-12-0021
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Application Practice and Reflection on Medical Device Product Technical Requirements
Ye Chenghong, Li Jinfang, Wang Yongqing
2025, 39(5): 506-510.
https://doi.org/10.16153/j.1002-7777.2024-10-0026
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Current Status and Countermeasures of Self-testing for
in vitro
Diagnostic Reagent Registration
Cai Jiangbo, Cui Jia, Chang Yongsheng, Chen Yu, Qiu Jing, Yu Yang
2025, 39(5): 511-516.
https://doi.org/10.16153/j.1002-7777.2025-03-0005
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Analysis on the Current Situation and Problems of Geographical Indication Protection of Authentic Medicinal Materials in China under “Three-track System”
Chen Yang, Kang Qi, Huang Qianqian
2025, 39(5): 517-527.
https://doi.org/10.16153/j.1002-7777.2024-11-0023
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Enlightenment of “Hong Kong and Macao Medicine and Equipment Connect” and Lecheng Pilot Zone Policy on Anti-tumor Drug Regulation
Chen Hongwei, Zhu Hong, Gao Meixiang, Cai Minxiang, Li Ya, Yang Jiaan, Yin Yiru, Feng Haohao
2025, 39(5): 528-537.
https://doi.org/10.16153/j.1002-7777.2024-12-0043
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Analysis of Key Points in Environmental Monitoring of Sterile Preparations Manufacturing Based on the GMP Inspection Perspective
Li Lei, Ban Yongsheng
2025, 39(5): 538-544.
https://doi.org/10.16153/j.1002-7777.2024-12-0027
Abstract
(
)
Download PDF
(
)
Supervision & Administration
Research and Prospect on the Label Management of National Drug Standard Materials
Wang Yajun, Yin Huidong, Liu Huanping, Liu Mingli
2025, 39(5): 545-551.
https://doi.org/10.16153/j.1002-7777.2024-10-0034
Abstract
(
)
Download PDF
(
)
More +
More +
More +
More +
More +
Links
More
